| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |